Company news
Corvus Pharmaceuticals, Inc. news in 2020
Corvus Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & Exposition
December 5, 2020
Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition
November 29, 2020
Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
November 10, 2020
Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 8, 2020
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
October 28, 2020
Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
October 4, 2020
Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors
September 10, 2020
Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19
September 9, 2020
Corvus Announces Participation in Upcoming Investor Conferences
September 7, 2020
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
July 29, 2020
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020
July 22, 2020
Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19
July 6, 2020
Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant
May 28, 2020
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
April 29, 2020
Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2020 Financial Results on April 30, 2020
April 21, 2020
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
March 4, 2020
Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1b/2 Clinical Trial of Ciforadenant at the 2020 American Society of Clinical Oncology’s Genitourinary Cancers Symposium
February 12, 2020
Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum
January 31, 2020
Decks in 2020
- Technical Presentation (2020)
Technical · 17 slides · 2020